Pathophysiology and inhibition of IL-23 signaling in psoriatic arthritis : A molecular insight

Copyright © 2018 Elsevier Inc. All rights reserved.

Détails bibliographiques
Publié dans:Clinical immunology (Orlando, Fla.). - 1999. - 206(2019) vom: 01. Sept., Seite 15-22
Auteur principal: Nguyen, Cuong Thach (Auteur)
Autres auteurs: Bloch, Yehudi, Składanowska, Katarzyna, Savvides, Savvas N, Adamopoulos, Iannis E
Format: Article en ligne
Langue:English
Publié: 2019
Accès à la collection:Clinical immunology (Orlando, Fla.)
Sujets:Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review Cytokines Human monoclonal IL-23 antibodies IL-23/IL-23R pathways Psoriatic arthritis Skin and joint inflammation Therapeutics plus... Antibodies, Monoclonal, Humanized Dermatologic Agents Interleukin-23 secukinumab DLG4EML025 Ustekinumab FU77B4U5Z0